Literature DB >> 2483722

Granulocyte colony-stimulating factor: preclinical and clinical studies.

J L Gabrilove1, A Jakubowski.   

Abstract

The production of neutrophil granulocytes is a complex and dynamic process during which a small number of self-renewing stem cells give rise to lineage-specific progenitors. One hematopoietic glycoprotein that appears to specifically control the survival, cycle activation, proliferation and terminal maturation of this myeloid lineage is granulocyte colony-stimulating factor (G-CSF). Some topics discussed are its molecular characterization, biochemical purification, sources, and effects of administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483722

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  2 in total

1.  Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on murine resistance against Listeria monocytogenes.

Authors:  B A Serushago; Y Yoshikai; T Handa; M Mitsuyama; K Muramori; K Nomoto
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer.

Authors:  K Eguchi; T Shinkai; Y Sasaki; T Tamura; Y Ohe; K Nakagawa; M Fukuda; K Yamada; A Kojima; F Oshita
Journal:  Jpn J Cancer Res       Date:  1990-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.